Aurobindo Pharma Share price target & analyst calls

₹1,610.9+32.10 (+2.03%)

Avg 1-year target

9 of 11 long-term calls BUY

₹1,622.140.7% above today's price

Aurobindo Pharma's average 1-year share price target is ₹1,622.14, the average of 7 advisors' latest targets. Targets range from ₹950 to ₹1,955.

Latest: HSBC Securities ₹1,955 · 7 Oct 2026

12
9 BUY · 3 SELL, all horizons
7
with an active 1Y target
39%
37 of 95 closed calls hit
109
all horizons, open and closed

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Aurobindo Pharma target price by brokerage

Each advisor's latest 1-year target · 7 advisors · tap a row for the call

All tips (109)

BUYTarget₹1,955
HSbyHSBC Securities+21.4% to target
1 Year* · 12 mo left · 7 Oct 2026 · entry ₹1,696.2 · via Zee Business (Live)P&L -5.0%
BUYTarget₹1,800
MObyMotilal Oswal+11.7% to target
1 Year* · 10 mo left · 7 Aug 2026 · entry ₹1,668 · via CNBC Awaaz.P&L -3.4%
BUYTarget₹1,800
CbyCitigroup+11.7% to target
1 Year* · 10 mo left · 7 Aug 2026 · entry ₹1,625.4 · via CNBC Awaaz.P&L -0.9%
BUYTarget₹1,900
HSbyHSBC Securities+17.9% to target
1 Year* · 10 mo left · 7 Aug 2026 · entry ₹1,580.1 · via CNBC Awaaz.P&L +1.9%
BUYTarget₹1,750
GSbyGoldman Sachs+8.6% to target
1 Year* · 10 mo left · 7 Aug 2026 · entry ₹1,580.1 · via CNBC Awaaz.P&L +1.9%
BUYTarget₹1,860
MObyMotilal Oswal+15.5% to target
1 Year* · 10 mo left · 6 Aug 2026 · entry ₹1,588.9 · via Institutional / Brokerage ResearchP&L +1.4%
BUYTarget₹1,850
GSbyGoldman Sachs+14.8% to target
1 Year* · 10 mo left · 6 Aug 2026 · entry ₹1,625 · via ET Now (Live)P&L -0.9%
SELLTarget₹1,300
MbyMacquarie+19.3% to target
1 Year* · 10 mo left · 6 Aug 2026 · entry ₹1,625 · via CNBC Awaaz.P&L +0.9%
SELLTarget₹950
EGbyEmkay Global+41.0% to target
1 Year* · 9 mo left · 27 Jul 2026 · entry ₹1,533.5 · via ET Now (Live)P&L -5.0%
BUYTarget₹1,800
1 Year · 9 mo left · 8 Jul 2026 · entry ₹1,550 · via CNBC Awaaz.P&L +3.9%
BUYTarget₹1,750
1 Year · 9 mo left · 7 Jul 2026 · entry ₹1,530 · via CNBC Awaaz.P&L +5.3%
BUYTarget₹1,600
CbyCLSATarget hit
1 Year* · 7 Aug 2026 · entry ₹1,580.1 · via CNBC Awaaz.exit ₹1,600
BUYTarget₹1,580
1 Year* · 22 Jun 2026 · entry ₹1,497.8 · via NDTV Profit (Live)exit ₹1,580
BUYTarget₹1,502
1 Year* · 1 Apr 2026 · entry ₹1,342.1 · via Institutional / Brokerage Researchexit ₹1,502
BUYTarget₹1,500
1 Year* · 23 Mar 2026 · entry ₹1,278.7 · via Institutional / Brokerage Researchexit ₹1,500
BUYTarget₹1,425
1 Year* · 15 Feb 2026 · entry ₹1,145.6 · via Institutional / Brokerage Researchexit ₹1,425
BUYTarget₹1,294
1 Year* · 10 Feb 2026 · entry ₹1,124.1 · via Institutional / Brokerage Researchexit ₹1,294
BUYTarget₹1,390
1 Year* · 10 Feb 2026 · entry ₹1,145.6 · via Institutional / Brokerage Researchexit ₹1,390
BUYTarget₹1,430
1 Year* · 3 Dec 2025 · entry ₹1,208.9 · via Institutional / Brokerage Researchexit ₹1,430
BUYTarget₹1,375
1 Year* · 10 Nov 2025 · entry ₹1,154.8 · via Institutional / Brokerage Researchexit ₹1,375
BUYTarget₹1,350
1 Year* · 7 Nov 2025 · entry ₹1,123.8 · via Institutional / Brokerage Researchexit ₹1,350
BUYTarget₹1,345
1 Year* · 7 Nov 2025 · entry ₹1,123.8 · via Institutional / Brokerage Researchexit ₹1,345
BUYTarget₹1,316
1 Year* · 6 Nov 2025 · entry ₹1,140.6 · via Institutional / Brokerage Researchexit ₹1,316
BUYTarget₹1,350
1 Year* · 6 Nov 2025 · entry ₹1,140.6 · via Institutional / Brokerage Researchexit ₹1,350
BUYTarget₹1,300
1 Year* · 6 Aug 2025 · entry ₹1,072.3 · via Institutional / Brokerage Researchexit ₹1,300
BUYTarget₹1,400
1 Year* · 6 Aug 2025 · entry ₹1,079.3 · via Institutional / Brokerage Researchexit ₹1,400
BUYTarget₹1,300
1 Year* · 5 Aug 2025 · entry ₹1,079.3 · via Institutional / Brokerage Researchexit ₹1,300
BUYTarget₹1,251
1 Year* · 5 Aug 2025 · entry ₹1,079.3 · via Institutional / Brokerage Researchexit ₹1,251
BUYTarget₹1,348
1 Year* · 4 Jul 2025 · entry ₹1,191.3 · via Institutional / Brokerage Researchexit ₹1,348
BUYTarget₹1,440
1 Year* · 27 May 2025 · entry ₹1,191.2 · via Institutional / Brokerage Researchexit ₹1,440
BUYTarget₹1,475
1 Year* · 28 May 2024 · entry ₹1,221 · via Institutional / Brokerage Researchexit ₹1,475
BUYTarget₹1,185
1 Year* · 4 Mar 2024 · entry ₹1,090.9 · via Institutional / Brokerage Researchexit ₹1,185
BUYTarget₹1,160
1 Year* · 13 Feb 2024 · entry ₹1,026.4 · via Institutional / Brokerage Researchexit ₹1,160
BUYTarget₹1,451
1 Year* · 17 Mar 2025 · entry ₹1,111.7 · via Institutional / Brokerage Researchexit ₹1,286
BUYTarget₹1,510
1 Year* · 10 Feb 2025 · entry ₹1,177.15 · via Institutional / Brokerage Researchexit ₹1,124.1
BUYTarget₹1,500
1 Year* · 10 Feb 2025 · entry ₹1,177.15 · via Institutional / Brokerage Researchexit ₹1,124.1
BUYTarget₹1,445
1 Year* · 8 Feb 2025 · entry ₹1,191.7 · via Institutional / Brokerage Researchexit ₹1,191
BUYTarget₹1,540
1 Year* · 27 Nov 2024 · entry ₹1,223.4 · via Institutional / Brokerage Researchexit ₹1,235.8
BUYTarget₹1,580
1 Year* · 19 Nov 2024 · entry ₹1,250.1 · via Institutional / Brokerage Researchexit ₹1,235.8
BUYTarget₹1,460
1 Year* · 12 Nov 2024 · entry ₹1,267.4 · via Institutional / Brokerage Researchexit ₹1,183.6
BUYTarget₹1,532
1 Year* · 11 Nov 2024 · entry ₹1,289.05 · via Institutional / Brokerage Researchexit ₹1,168.2
BUYTarget₹1,785
1 Year* · 13 Aug 2024 · entry ₹1,505.8 · via Institutional / Brokerage Researchexit ₹1,078.2
BUYTarget₹1,612
1 Year* · 13 Aug 2024 · entry ₹1,505.8 · via Institutional / Brokerage Researchexit ₹1,078.2
BUYTarget₹1,700
1–3 Months · 18 Aug 2026 · entry ₹1,600 · via NDTV Profitexit ₹1,700
BUYTarget₹1,800
1–3 Months* · 24 Sept 2026 · entry ₹1,734 · via Business Todayexit ₹1,680
BUYTarget₹1,680
1–3 Months* · 29 Jul 2026 · entry ₹1,556.7 · via CNBC Awaaz.exit ₹1,545
BUYTarget₹1,500
1–3 Months · 6 Apr 2026 · entry ₹1,280 · via ET Now
BUYTarget₹1,600
1–3 Months · 1 Apr 2026 · entry ₹1,339.6 · via NDTV Profitexit ₹1,552.6
SELLTarget₹1,540
1–2 Weeks* · 12d left · 21 Oct 2026 · entry ₹1,606.2 · via CNBC Awaaz.P&L -0.3%
BUYTarget₹1,730
1–2 Weeks* · 17 Sept 2026 · entry ₹1,683.2 · via CNBC Awaaz.exit ₹1,730

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Full call history, all horizons: page 2 of 3

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks